These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 7646825)

  • 1. New antimalarials. A risk-benefit analysis.
    Nosten F; Price RN
    Drug Saf; 1995 Apr; 12(4):264-73. PubMed ID: 7646825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetic and pharmacodynamic modelling of artemisinin and mefloquine enantiomers in patients with falciparum malaria.
    Svensson US; Alin H; Karlsson MO; Bergqvist Y; Ashton M
    Eur J Clin Pharmacol; 2002 Aug; 58(5):339-51. PubMed ID: 12185558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mefloquine and halofantrine, new therapeutic drugs of malaria].
    Le Bras J; Ringwald P; Monsérié C; Basco LK
    Rev Med Interne; 1991; 12(1):68-74. PubMed ID: 2041918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malaria.
    ter Kuile FO; Dolan G; Nosten F; Edstein MD; Luxemburger C; Phaipun L; Chongsuphajaisiddhi T; Webster HK; White NJ
    Lancet; 1993 Apr; 341(8852):1044-9. PubMed ID: 8096956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compliance with a 2 day course of artemether-mefloquine in an area of highly multi-drug resistant Plasmodium falciparum malaria.
    Na-Bangchang K; Congpuong K; Sirichaisinthop J; Suprakorb K; Karbwang J
    Br J Clin Pharmacol; 1997 Jun; 43(6):639-42. PubMed ID: 9205825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
    Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inoculum effect leads to overestimation of in vitro resistance for artemisinin derivatives and standard antimalarials: a Gambian field study.
    Duraisingh MT; Jones P; Sambou I; von Seidlein L; Pinder M; Warhurst DC
    Parasitology; 1999 Nov; 119 ( Pt 5)():435-40. PubMed ID: 10599075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of multidrug-resistant Plasmodium falciparum in Thailand: in vitro tracking.
    Wongsrichanalai C; Webster HK; Wimonwattrawatee T; Sookto P; Chuanak N; Thimasarn K; Wernsdorfer WH
    Am J Trop Med Hyg; 1992 Jul; 47(1):112-6. PubMed ID: 1636877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six-years monitoring the efficacy of the combination of artesunate and mefloquine for the treatment of uncomplicated falciparum malaria.
    Wattanakoon Y; Chittamas S; Pornkulprasit V; Kanda T; Thimasarn K; Rojanawatsirivej C; Looareesuwan S; Bunnag D
    Southeast Asian J Trop Med Public Health; 2003 Sep; 34(3):542-5. PubMed ID: 15115124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artesunate and mefloquine given simultaneously for three days via a prepacked blister is equally effective and tolerated as a standard sequential treatment of uncomplicated acute Plasmodium falciparum malaria: randomized, double-blind study in Thailand.
    Krudsood S; Looareesuwan S; Silachamroon U; Chalermrut K; Pittrow D; Cambon N; Mueller EA
    Am J Trop Med Hyg; 2002 Nov; 67(5):465-72. PubMed ID: 12479545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimalarial drug resistance and combination chemotherapy.
    White N
    Philos Trans R Soc Lond B Biol Sci; 1999 Apr; 354(1384):739-49. PubMed ID: 10365399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type RI resistance to halofantrine in West Africa.
    Basco LK; Le Bras J; Gillotin C; Ringwald P; Rabenjarson E; Gimenez F; Bouchaud O; Farinotti R; Coulaud JP
    Trop Med Parasitol; 1991 Dec; 42(4):413-4. PubMed ID: 1665577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo-in vitro model for the assessment of clinically relevant antimalarial cross-resistance.
    Noedl H; Wernsdorfer WH; Krudsood S; Wilairatana P; Viriyavejakul P; Kollaritsch H; Wiedermann G; Looareesuwan S
    Am J Trop Med Hyg; 2001 Dec; 65(6):696-9. PubMed ID: 11791959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives.
    Price R; van Vugt M; Phaipun L; Luxemburger C; Simpson J; McGready R; ter Kuile F; Kham A; Chongsuphajaisiddhi T; White NJ; Nosten F
    Am J Trop Med Hyg; 1999 Apr; 60(4):547-55. PubMed ID: 10348227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Halofantrine for the treatment of mefloquine chemoprophylaxis failures in Plasmodium falciparum infections.
    Shanks GD; Watt G; Edstein MD; Webster HK; Suriyamongkol V; Watanasook C; Panpunnung S; Kowinwiphat W
    Am J Trop Med Hyg; 1991 Oct; 45(4):488-91. PubMed ID: 1951857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study.
    Nosten F; van Vugt M; Price R; Luxemburger C; Thway KL; Brockman A; McGready R; ter Kuile F; Looareesuwan S; White NJ
    Lancet; 2000 Jul; 356(9226):297-302. PubMed ID: 11071185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative trial on the response of Plasmodium falciparum to halofantrine and mefloquine in Trat Province, eastern Thailand.
    Ketrangsee S; Vijaykadga S; Yamokgul P; Jatapadma S; Thimasarn K; Rooney W
    Southeast Asian J Trop Med Public Health; 1992 Mar; 23(1):55-8. PubMed ID: 1523479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artemisinin drugs: novel antimalarial agents.
    Price RN
    Expert Opin Investig Drugs; 2000 Aug; 9(8):1815-27. PubMed ID: 11060779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of patients with recrudescent falciparum malaria with a sequential combination of artesunate and mefloquine.
    Looareesuwan S; Kyle DE; Viravan C; Vanijanonta S; Wilairatana P; Charoenlarp P; Canfield CJ; Webster HK
    Am J Trop Med Hyg; 1992 Dec; 47(6):794-9. PubMed ID: 1471736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin.
    Sidhu AB; Uhlemann AC; Valderramos SG; Valderramos JC; Krishna S; Fidock DA
    J Infect Dis; 2006 Aug; 194(4):528-35. PubMed ID: 16845638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.